By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German protein research firm Protagen this week said it and MicroDiscovery are collaborating to identify and validate biomarkers.

Protagen will use its UNIArray technology platform while MicroDiscovery will incorporate its software for the analysis of complex biomarker panels as part of the collaboration.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.